Factors and preventive strategies for perioperative euglycemic diabetic ketoacidosis in patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors: a retrospective study

Abstract Background Invasive treatment and the associated stress are known risk factors for sodium-glucose cotransporter 2 inhibitor (SGLT2i)-induced euglycemic diabetic ketoacidosis (euDKA) development. It is recommended that SGLT2is is discontinued at least 3 days prior to a scheduled surgery. How...

Full description

Bibliographic Details

Published in:	Journal of Pharmaceutical Health Care and Sciences
Main Authors:	Miho Takemura, Kenji Ikemura, Masahiro Okuda
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	Sodium-glucose cotransporter 2 inhibitor Euglycemic diabetic ketoacidosis Risk factors Prevention strategies
Online Access:	https://doi.org/10.1186/s40780-025-00487-6